The first anticipated collaboration will include paid testing of several liquid products to be dried in vials using pilot-scale REV™ machinery at EnWave’s Innovation Center in Delta, British Columbia.

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a master service agreement (the “Agreement”) with BioTechnique, an American pharmaceutical ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

Already known for its antibody drug conjugates (ADCs), lipid nanoparticles (LNPs), lyophilization development ... In addition to increasing batch sizes up to 20,000 vials, the new capacity will ...

Colombo, March 17 (Daily Mirror) - The Vehicle Importers Association of Lanka (VIAL) claimed today that around 400 vehicles have been stuck at the Sri Lanka Customs for over 20 days due to a ...

Already known for its antibody drug conjugates (ADCs), lipid nanoparticles (LNPs), lyophilization development ... increasing batch sizes up to 20,000 vials, the new capacity will feature robotic ...